# Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

> **NCT02354001** · PHASE4 · COMPLETED · sponsor: **The Alfred** · enrollment: 80 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Raloxifene hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02354001
- **Lead sponsor:** The Alfred
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02354001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02354001, "Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02354001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*